Staphylococcus Aureus Infections Global Clinical Trials Review, H2, 2011

Request for Sample Pages

Published Date : 19 December 2011

Pages : 112

Add to Cart - Staphylococcus Aureus Infections Global Clinical Trials Review, H2, 2011

Staphylococcus Aureus Infections Global Clinical Trials Review, H2, 2011

Summary

GlobalDatas clinical trial report, Staphylococcus Aureus Infections Global Clinical Trials Review, H2, 2011 provides data on the Staphylococcus Aureus Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Staphylococcus Aureus Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Staphylococcus Aureus Infections . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents :

List of Tables 5
List of Figures 7
Introduction 8
Staphylococcus Aureus Infections 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Staphylococcus Aureus Infections 25
Subjects Recruited Over a Period of Time 28
Prominent Sponsors 29
Top Companies Participating in Staphylococcus Aureus Infections Therapeutics Clinical Trials 31
Prominent Drug Comparison 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
AstraZeneca PLC 35
Clinical Trial Overview of AstraZeneca PLC 35
Merck & Co., Inc. 36
Clinical Trial Overview of Merck & Co., Inc. 36
GlaxoSmithKline plc 37
Clinical Trial Overview of GlaxoSmithKline plc 37
PolyMedix, Inc. 38
Clinical Trial Overview of PolyMedix, Inc. 38
CrystalGenomics, Inc. 39
Clinical Trial Overview of CrystalGenomics, Inc. 39
Theravance, Inc. 40
Clinical Trial Overview of Theravance, Inc. 40
Enanta Pharmaceuticals, Inc. 41
Clinical Trial Overview of Enanta Pharmaceuticals, Inc. 41
Peplin Inc. 42
Clinical Trial Overview of Peplin Inc. 42
Bio-K+ International Inc. 43
Clinical Trial Overview of Bio-K+ International Inc. 43
Lytix Biopharma AS 44
Clinical Trial Overview of Lytix Biopharma AS 44
Trius Therapeutics, Inc. 45
Clinical Trial Overview of Trius Therapeutics, Inc. 45
Cempra Pharmaceuticals, Inc. 46
Clinical Trial Overview of Cempra Pharmaceuticals, Inc. 46
Nitric Biotherapeutics, Inc. 47
Clinical Trial Overview of Nitric Biotherapeutics, Inc. 47
3M Health Care 48
Clinical Trial Overview of 3M Health Care 48
Inova Health System 49
Clinical Trial Overview of Inova Health System 49
Harvard Pilgrim Health Care, Inc. 50
Clinical Trial Overview of Harvard Pilgrim Health Care, Inc. 50
Inhibitex, Inc. 51
Clinical Trial Overview of Inhibitex, Inc. 51
Wockhardt Limited 52
Clinical Trial Overview of Wockhardt Limited 52
Johnson & Johnson 53
Clinical Trial Overview of Johnson & Johnson 53
Clinical Trial Overview of Top Universities / Institutes / Hospitals 54
The National Institute of Allergy and Infectious Diseases 54
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 54
Tel-Aviv Sourasky Medical Center 55
Clinical Trial Overview of Tel-Aviv Sourasky Medical Center 55
Uniformed Services University of the Health Sciences (USU) 56
Clinical Trial Overview of Uniformed Services University of the Health Sciences (USU) 56
Hopitaux Universitaires de Geneve 57
Clinical Trial Overview of Hopitaux Universitaires de Geneve 57
University of California, Irvine 58
Clinical Trial Overview of University of California, Irvine 58
University of Pittsburgh 59
Clinical Trial Overview of University of Pittsburgh 59
The University of British Columbia 60
Clinical Trial Overview of The University of British Columbia 60
Christiana Care Health System 61
Clinical Trial Overview of Christiana Care Health System 61
Virginia Commonwealth University 62
Clinical Trial Overview of Virginia Commonwealth University 62
The University of Chicago 63
Clinical Trial Overview of The University of Chicago 63
Wilford Hall Medical Center 64
Clinical Trial Overview of Wilford Hall Medical Center 64
The Childrens Mercy Hospital 65
Clinical Trial Overview of The Childrens Mercy Hospital 65
John D. Dingell VA Medical Center 66
Clinical Trial Overview of John D. Dingell VA Medical Center 66
Veterans Affairs Medical Center 67
Clinical Trial Overview of Veterans Affairs Medical Center 67
University of Colorado 68
Clinical Trial Overview of University of Colorado 68
CAMC Health System 69
Clinical Trial Overview of CAMC Health System 69
Boston Medical Center 70
Clinical Trial Overview of Boston Medical Center 70
University of Washington 71
Clinical Trial Overview of University of Washington 71
University of Kentucky 72
Clinical Trial Overview of University of Kentucky 72
University of Michigan 73
Clinical Trial Overview of University of Michigan 73
Five Key Clinical Profiles 74
Appendix 109
Abbreviations 109
Definitions 109
Research Methodology 110
Secondary Research 110
About GlobalData 111
Contact Us 111
Disclaimer 111
Source 112

List of Tables
Staphylococcus Aureus Infections Therapeutics Market, Global, Clinical Trials by Zone, 2011* 9
Staphylococcus Aureus Infections Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 10
Staphylococcus Aureus Infections Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 11
Staphylococcus Aureus Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2011* 12
Staphylococcus Aureus Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2011* 13
Staphylococcus Aureus Infections Therapeutics Clinical Trials, North America, Top Countries, 2011* 14
Staphylococcus Aureus Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011* 15
Staphylococcus Aureus Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2011* 16
Staphylococcus Aureus Infections Therapeutics Clinical Trials, BRIC Countries, 2011* 17
Staphylococcus Aureus Infections Therapeutics Clinical Trials, G7 Countries, 2011* 18
Staphylococcus Aureus Infections Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011* 19
Staphylococcus Aureus Infections Therapeutics Clinical Trials, E7 Countries, 2011* 20
Staphylococcus Aureus Infections Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011* 21
Staphylococcus Aureus Infections Therapeutics Market, Global, Clinical Trials by Phase, 2011* 22
Staphylococcus Aureus Infections Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011* 23
Staphylococcus Aureus Infections Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 24
Staphylococcus Aureus Infections Therapeutics Market, Global, Suspended Clinical Trials, 2011* 25
Staphylococcus Aureus Infections Therapeutics Market, Global, Withdrawn Clinical Trials, 2011* 26
Staphylococcus Aureus Infections Therapeutics Market, Global, Terminated Clinical Trials, 2011* 27
Staphylococcus Aureus Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 28
Staphylococcus Aureus Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 30
Staphylococcus Aureus Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 32
Staphylococcus Aureus Infection Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 33
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2011* 34
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2011* 35
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2011* 36
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2011* 37
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by PolyMedix, Inc., 2011* 38
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by CrystalGenomics, Inc., 2011* 39
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Theravance, Inc., 2011* 40
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Enanta Pharmaceuticals, Inc., 2011* 41
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Peplin Inc., 2011* 42
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Bio-K+ International Inc., 2011* 43
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Lytix Biopharma AS, 2011* 44
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Trius Therapeutics, Inc., 2011* 45
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Cempra Pharmaceuticals, Inc., 2011* 46
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Nitric Biotherapeutics, Inc., 2011* 47
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by 3M Health Care, 2011* 48
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Inova Health System, 2011* 49
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Harvard Pilgrim Health Care, Inc., 2011* 50
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Inhibitex, Inc., 2011* 51
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Wockhardt Limited, 2011* 52
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2011* 53
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2011* 54
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Tel-Aviv Sourasky Medical Center, 2011* 55
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Uniformed Services University of the Health Sciences (USU), 2011* 56
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopitaux Universitaires de Geneve, 2011* 57
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Irvine, 2011* 58
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2011* 59
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of British Columbia, 2011* 60
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Christiana Care Health System, 2011* 61
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Virginia Commonwealth University, 2011* 62
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2011* 63
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Wilford Hall Medical Center, 2011* 64
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The Childrens Mercy Hospital, 2011* 65
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by John D. Dingell VA Medical Center, 2011* 66
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Veterans Affairs Medical Center, 2011* 67
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2011* 68
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by CAMC Health System, 2011* 69
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Medical Center, 2011* 70
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2011* 71
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kentucky, 2011* 72
Staphylococcus Aureus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2011* 73

List of Figures
Staphylococcus Aureus Infections Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 9
Staphylococcus Aureus Infections Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 10
Staphylococcus Aureus Infections Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 11
Staphylococcus Aureus Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011* 12
Staphylococcus Aureus Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011* 13
Staphylococcus Aureus Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2011* 14
Staphylococcus Aureus Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2011* 15
Staphylococcus Aureus Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2011* 16
Staphylococcus Aureus Infections Therapeutics Clinical Trials, BRIC Countries (%), 2011* 17
Staphylococcus Aureus Infections Therapeutics Clinical Trials, G7 Countries (%), 2011* 18
Staphylococcus Aureus Infections Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011* 19
Staphylococcus Aureus Infections Therapeutics Clinical Trials, E7 Countries (%), 2011* 20
Staphylococcus Aureus Infections Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011* 21
Staphylococcus Aureus Infections Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 22
Staphylococcus Aureus Infections Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011* 23
Staphylococcus Aureus Infections Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 24
Staphylococcus Aureus Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 28
Staphylococcus Aureus Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 29
Staphylococcus Aureus Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 31
Staphylococcus Aureus Infection Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 33
GlobalData Methodology 110

Published By : GlobalData

PDF Format Reports will be
delivered by email within
12 to 24 hours after placing
the order (Mon-Fri IST)

Australia Research Reports
Brazil Research Reports
Asia Research Reports
China Research Reports
Canada Research Reports
Europe Research Reports
France Research Reports
Egypt Research Reports
Global Research Reports
Greece Research Reports
Germany Research Reports
Japan Research Reports
India Research Reports
Ireland Research Reports
Korea Research Reports
Mexico Research Reports
Maldives Research Reports
New Zealand Research Reports
Netherland Research Reports
Poland Research Reports
Russia Research Reports
South Africa Research Reports
Sri Lanka Research Reports
Singapore Research Reports
Switzerland Research Reports
UK Research Reports
USA Research Reports
UAE Research Reports
Uruguay Research Reports

ExxonMobil Company Analysis
Toyota Motors Company Analysis
ConocoPhillips Company Analysis
Sinopec Company Analysis
Total S.A. Company Analysis
Verizon Company Analysis
Gazprom Company Analysis
JPMorgan Company Analysis
Chevron Company Analysis
E.ON Company Analysis
PetroChina Company Analysis
Allianz Company Analysis
AXA Company Analysis
Carrefour Company Analysis
General Electric Company Analysis
Bank of America Company
Assicurazioni Generali Company
Samsung Electronics Company
GDF Suez Company Analysis
McKesson Corporation Company
Volkswagen Group Company
Royal Dutch Shell Company